Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
The COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson’s disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a compr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/13/7/1114 |
_version_ | 1797590018275934208 |
---|---|
author | Rodrigo León-García Emmanuel Ortega-Robles Oscar Arias-Carrión |
author_facet | Rodrigo León-García Emmanuel Ortega-Robles Oscar Arias-Carrión |
author_sort | Rodrigo León-García |
collection | DOAJ |
description | The COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson’s disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a comprehensive analysis of the data obtained during the period of COVID-19 lockdown, comparing it with analogous timeframes in 2018 and 2019. Our objective was to examine the influence of this unique circumstance on both motor and non-motor symptoms in patients with PD. Telemedicine was employed to assess symptoms using the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Our findings revealed a notable worsening of symptoms, evidenced by a significant increase in the total MDS-UPDRS score. Specifically, there was an increase in Part III scores, reflecting changes in motor function. However, no differences were observed in Parts I or II, which pertain to non-motor symptoms. Additionally, patient satisfaction and the feasibility of telemedicine consultations were high, highlighting the efficacy of this alternative approach during the pandemic. The COVID-19 pandemic had a discernible impact on PD symptoms, with a significant worsening of motor symptoms observed during the lockdown period. Telemedicine was a valuable tool for remote assessment and follow-up, ensuring continuity of care for individuals with PD in the face of pandemic-related challenges. |
first_indexed | 2024-03-11T01:14:23Z |
format | Article |
id | doaj.art-30b9adcdac734f24a00e4ca10af217a2 |
institution | Directory Open Access Journal |
issn | 2076-3425 |
language | English |
last_indexed | 2024-03-11T01:14:23Z |
publishDate | 2023-07-01 |
publisher | MDPI AG |
record_format | Article |
series | Brain Sciences |
spelling | doaj.art-30b9adcdac734f24a00e4ca10af217a22023-11-18T18:35:34ZengMDPI AGBrain Sciences2076-34252023-07-01137111410.3390/brainsci13071114Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in MexicoRodrigo León-García0Emmanuel Ortega-Robles1Oscar Arias-Carrión2Unidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, MexicoUnidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, MexicoUnidad de Trastornos del Movimiento y Sueño, Hospital General Dr. Manuel Gea González, Calzada de Tlalpan 4800, Mexico City 14080, MexicoThe COVID-19 pandemic introduced unprecedented challenges in managing patients with Parkinson’s disease (PD) due to disruptions in healthcare services and the need for social distancing. Understanding the effects of COVID-19 on PD symptoms is crucial for optimizing patient care. We conducted a comprehensive analysis of the data obtained during the period of COVID-19 lockdown, comparing it with analogous timeframes in 2018 and 2019. Our objective was to examine the influence of this unique circumstance on both motor and non-motor symptoms in patients with PD. Telemedicine was employed to assess symptoms using the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Our findings revealed a notable worsening of symptoms, evidenced by a significant increase in the total MDS-UPDRS score. Specifically, there was an increase in Part III scores, reflecting changes in motor function. However, no differences were observed in Parts I or II, which pertain to non-motor symptoms. Additionally, patient satisfaction and the feasibility of telemedicine consultations were high, highlighting the efficacy of this alternative approach during the pandemic. The COVID-19 pandemic had a discernible impact on PD symptoms, with a significant worsening of motor symptoms observed during the lockdown period. Telemedicine was a valuable tool for remote assessment and follow-up, ensuring continuity of care for individuals with PD in the face of pandemic-related challenges.https://www.mdpi.com/2076-3425/13/7/1114COVID-19Parkinson’s diseasemotor symptomsnon-motor symptomstelemedicine |
spellingShingle | Rodrigo León-García Emmanuel Ortega-Robles Oscar Arias-Carrión Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico Brain Sciences COVID-19 Parkinson’s disease motor symptoms non-motor symptoms telemedicine |
title | Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico |
title_full | Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico |
title_fullStr | Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico |
title_full_unstemmed | Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico |
title_short | Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico |
title_sort | remote assessment of parkinson s disease patients amidst the covid 19 lockdown in mexico |
topic | COVID-19 Parkinson’s disease motor symptoms non-motor symptoms telemedicine |
url | https://www.mdpi.com/2076-3425/13/7/1114 |
work_keys_str_mv | AT rodrigoleongarcia remoteassessmentofparkinsonsdiseasepatientsamidstthecovid19lockdowninmexico AT emmanuelortegarobles remoteassessmentofparkinsonsdiseasepatientsamidstthecovid19lockdowninmexico AT oscarariascarrion remoteassessmentofparkinsonsdiseasepatientsamidstthecovid19lockdowninmexico |